Treatment of Acute Mood Depressive Episode in Borderline Personality Disorder With rTMS
Part of paid clinical trials in Stanford, California.
- Sponsor
- Stanford University
- Study ID
- NCT04870255
- Status
- Recruiting
Conditions
- Borderline Personality Disorder
- Depressive Disorder, Major
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- Left Dorsolateral Prefrontal Cortex (L-DLPFC) — DEVICEParticipants who are randomly assigned to this group will receive active iTBS (intermittent theta burst stimulation) to the left DLPFC. Stimulation intensity will be standardized at 90% of resting motor threshold (adjusted for cortical depth). Stimulation will be delivered using the Magventure Magpro X100 TMS system.
- Dorsomedial Prefrontal Cortex (DMPFC) — DEVICEParticipants who are randomly assigned to this group will receive active iTBS (intermittent theta burst stimulation) to the DMPFC. Stimulation intensity will be standardized at 100% of resting motor threshold (adjusted for cortical depth). Stimulation will be delivered using the Magventure Magpro X100 TMS system.
- Sham Stimulation — DEVICEParticipants who are randomly assigned to this group will receive sham stimulation to the left DLPFC. Sham stimulation will be delivered using the Magventure Magpro X100 TMS system.
Study Details
This study evaluates the antidepressant effects of an accelerated schedule of theta-burst stimulation, termed accelerated intermittent theta-burst stimulation (aiTBS), in individuals with borderline personality disorder (BPD) or trait and comorbid mood depressive disorder (MDD) or bipolar II disorder in a current mood depressive episode (MDE).
Key Dates
- First listed
- May 3, 2021
- Start date
- Jul 20, 2021
- Status verified
- Aug 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 45 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Left Dorsolateral Prefrontal Cortex (L-DLPFC)The accelerated theta burst stimulation protocol will be applied to the left dorsolateral prefrontal cortex (L-DLPFC)
- Active Comparator: Dorsomedial Prefrontal Cortex (DMPFC)The accelerated theta burst stimulation protocol will be applied to the dorsomedial prefrontal cortex (DMPFC)
- Sham Comparator: Sham stimulationSham (non-active) stimulation will be applied to the left dorsolateral prefrontal cortex (DLPFC) region
Primary Outcome Measure
Change in the clinician rated Montgomery-Asberg Depression Rating Scale (MADRS-C) in active L-DLPFC vs. sham aiTBS. [ Time Frame: At baseline (pre-intervention), during the intervention and immediately after the intervention. ]
Central Contacts
- Bora Kim, MD, MAS650-800-6929
- Nick Bassano, MSW650-800-6929
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Stanford Hospital | Stanford | California | 94305 | Katina Marchione David Spiegel, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Stanford, CA
By condition
By specialty
By research site
Related Studies
- Biomarkers of Depression and Treatment ResponseRecruiting · University of California, San Francisco · San Francisco, California
- Delving Into Borderline Personality Disorder Clinical Trial ExperiencesNot Yet Recruiting · Power Life Sciences Inc. · San Francisco, California
- Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Major Depressive Disorder (MDD)Not Yet Recruiting · Neurovalens Ltd. · San Diego, California
- Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia SymptomsPHASE3 · Recruiting · Janssen Research & Development, LLC · Tucson, Arizona